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Abstract: Malignant myopericytoma is a rare entity with only 8
cases reported in the English literature. The authors report a case of
a 65-year-old man with a slow-growing 8-cm nodule on the right
arm. Marginal excision was performed, and a diagnosis of malignant
myopericytoma was made based on histopathologic and immuno-
histochemical aspects. These tumors are characterized by a pro-
liferation of round-to-spindle cells of myoid appearance in
a concentric perivascular arrangement, along with malignant cyto-
logical findings. By immunochemistry, the cells were positive for
smooth muscle actin and negative for desmin, cytokeratin AE1/AE3,
S100 protein, Melan-A, p63, CD99, bcl-2, CD10, and STAT-6. No
membranous expression of type IV collagen was observed. These
tumors are associated with aggressive biological behavior and most
develops metastases.
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INTRODUCTION
After Stout’s original description of hemangiopericytoma,1
it seems that a variety of “vascular” benign and malignant
tumors may have a hemangiopericytic pattern. Relationship
between hemangiopericytoma and pericytes was frequently
not confirmed by ultrastructural and immunohistochemical
evaluation. In 1996, Requena et al2 proposed the term myo-
pericytoma as an alternate name for solitary myofibroma,
basing their argument on its myopericytic differentiation.
In 1998, Granter et al3 adopted the term myopericytoma
and argued that myopericytoma, myofibromatosis, solitary
myofibroma, and infantile hemangiopericytoma form a single
morphological spectrum of tumors that show differentiation
toward perivascular myoid cells/pericytes. In 2002, McMenamin
and Fletcher4 broadened this spectrum with a report of
5 malignant myopericytomas (MMPCTs) and showed that
they are associated with aggressive biological behavior. We
performed a review of the English literature and found 3 addi-
tional cases described in the last 9 years.5–7 Finally, we report
a new case of MMPCT that shares the histological and
immunohistochemical findings as described by McMenamin
and Fletcher.4
CASE REPORT
We report a 65-year-old man who presented with a painless
tumor, which had been growing slowly for a few months on the right
arm. Physical examination revealed an 8-cm nodular tumor on
otherwise normal skin. His medical history was not significant. The
main clinical differential diagnosis was dermatofibrosarcoma protu-
berans. A surgical total excision was tried, and the specimen was
sent for histopathologic examination. Macroscopic examination
revealed a 7.6 · 6.0 cm nodule covered by a focally ulcerated epi-
dermis (Fig. 1). On section, the lesion occupied the entire dermis and
the subcutis with gray-whitish appearance and pushing rather than
infiltrating borders. Microscopic examination showed a dermal–
hypodermal unencapsulated confluence of poorly defined nodules
around discrete hemangiopericytoma-like vascular spaces (Fig.
2A). Perivascular concentric growth of tumor cells was present
(Fig. 2B). These nodules were composed of round-to-oval or short
spindle-shaped cells with amphophilic or eosinophilic pale cyto-
plasm. The cells showed ill-defined borders, vesicular nuclei, and
myoid features. Some areas of cells with central nuclei had glomus
FIGURE 1. Malignant myopericytoma. Ex vivo photography
of the cutaneous nodule.
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appearance (Fig. 3A). Nuclear pleomorphism was widespread with
large size, anisocariosis, multilobulation, macronucleoli, and giant
pseudoinclusions (Fig. 3B). A mitotic count of 22 mitoses per 10
high power fields (HPF) was identified. Necrosis “en masse,” lym-
phovascular invasion, and neural permeation were also observed
(Figs. 4A and B). Tumor cells stain diffusely for smooth muscle
actin (SMA) (Fig. 5) and calponin, and they were negative for des-
min, cytokeratin AE1/AE3, S100 protein, Melan-A, p63, CD99,
bcl-2, CD10, and STAT-6. No membranous expression of type IV
collagen was observed. Stain for CD34 was positive for the normal
endothelial cells and negative for tumor cells. The spectrum of his-
tomorphological and immunohistochemical findings was congruent
with a diagnosis of MMPCT. Staging studies were negative for
metastatic disease.
DISCUSSION
In 1998, Granter et al3 adopted the term myopericytoma
to describe a benign tumor with concentric perivascular pro-
liferation of oval-to-spindle cells that show apparent differen-
tiation toward perivascular myoid cells/pericytes. MMPCT
shows the same histological and immunohistochemical char-
acteristics but exhibit malignant features of the tumor cells as
high cellularity, high mitotic index, pleomorphism, necrosis,
and sometimes lymphovascular invasion and perineural infil-
tration. MMPCT are exceedingly rare and only 8 cases have
been reported in the English literature. We report a new case
of MMPCT based on the histopathologic and
immunohistochemical features described by McMenamin
and Fletcher,4 in the dermis and subcutis of the right arm.
In Table 1, we present an overview of the clinical data, gross
findings, treatment, and follow-up of these 9 cases. The larg-
est series of 5 cases was published by McMenamin and
Fletcher4 in 2002, and 3 others authors5–7 reported isolated
cases. In this review, the median age of occurrence was 54.5
years and the male:female ratio was 5:3. The tumors reported
had a wide anatomical distribution, arising subcutaneous/der-
mal or intramuscular in the extremities (n = 4), neck (n = 1),
or deep-seated location, mediastinum (n = 1) with dissemi-
nated metastatic disease at presentation, periampullary (n =
1), and left atrium (n = 1). Our case, like most, occurred in
a male and was located in the subcutaneous/dermal tissue of
an extremity. The presenting symptoms in 5 cases were
a growing mass,4,5 painful (cases 2 and 3),4 or painless (cases
1 and 4).4 Macroscopically, the average size of the tumor was
5.82 cm (1.5–13 cm). The size was not specified in 1 case.5
Most cases appeared well-defined but not encapsulated. Two
cases were ill-defined.4,5 The color of the lesions varied
(white, gray purple, tan, or red). Microscopically, 6 cases
showed a perivascular concentric growth accentuation.4,7 This
striking tendency for concentric perivascular growth is not
a feature in malignant glomus tumors.8,9 Vascular holes with
a staghorn pattern were present in 4 cases.4,7 Focal myxoid
stroma was described in 3 cases.4,6 A focal morphological
overlap with malignant glomus tumor was reported.4 The
FIGURE 2. A, Malignant myoper-
icytoma. Tumor cells around discrete
hemangiopericytoma-like vascular
spaces (H&E, ·200). B, Malignant
myopericytoma. Perivascular concen-
tric growth of tumor cell (H&E, ·400).
FIGURE 3. A, Malignant myoper-
icytoma. Areas of cells with glomus
appearance (H&E, ·400). B, Malig-
nant myopericytoma. Round-to-oval
cells with marked nuclear pleomor-
phism (H&E, ·400).
FIGURE 4. A, Malignant myoper-
icytoma. Lymphovascular invasion
(H&E, ·400). B, Malignant my-
opericytoma. Neural permeation
(H&E, ·400).
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tumor cells were round, oval, or spindle shaped. Nuclear
pleomorphism was seen with prominent nucleoli, hyperchro-
matism, and multilobulation in most tumors. Mitoses were
numerous in all cases with an average of 27/10 HPF (12–
48/10 HPF), and atypical mitotic figures were frequently
described. Necrosis was a feature in 5 cases.4,6,7 Vascular
invasion was a feature in 2 cases.4,6 Immunohistochemical
studies revealed that 7 cases were positive for SMA,4,5,7 in
1 case h-caldesmon was positive and SMA was not dis-
cussed.6 McMenamin and Fletcher4 interestingly described
a case where tumor cells were positive for SMA, and focally
for EMA and cytokeratin (AE1/AE3), the unique case in their
study with this immunohistochemical particularity. Desmin
expression was focally positive in case 3 of the McMenamin
series with a “dot-like” pattern of staining.
In view of the morphological findings, 2 pertinent
differential diagnoses are worth considering. Malignant
glomus tumor (glomangiosarcoma) is a closely related entity
within the pericytic family of tumors and can show morpho-
logic overlap. In contrast to MMPCTs, they do not show the
characteristic perivascular concentric multilayering of cells.
On occasion, there may be a residuum of precursor glomus
tumor around the malignant counterpart.8–11 It is now well-
established by some authors that malignant glomus tumors
have an immunohistochemical membranous expression of
collagen type IV.9–11 No evidence of membranous expression
of collagen type IV was found in our case.
Malignant solitary fibrous tumor is exceedingly rare;
all cutaneous tumors reported so far have behaved in
a benign fashion. Typical histologic features for malignant
solitary fibrous tumors are small fibroblast-like cells
FIGURE 5. Malignant myopericytoma. Tumor cells stain dif-
fusely for smooth muscle actin (H&E, ·400).
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arranged in the well-characterized “patternless pattern” of
architecture, hemangiopericytoma-like vessels and areas
with dense collagen along with malignant cytological fea-
tures, lymphovascular invasion, and neurotropism. In con-
trast to MMPCTs, they do not show the characteristic
perivascular concentric multilayering of cells. By immu-
nochemistry, these tumors express Vimentin, CD 34,
CD99, bcl-2, and STAT-6. In contrast to MMPCTs, they
do not show expression for SMA.
The therapeutic options were individually decided.
Marginal excision is the major option when metastases are
excluded after proper staging and was practiced in 5 cases.4,5,7
Three patients died after developed metastasis4 and 5 were
alive,4–7 3 of the 5 with metastatic disease.4,6,7
In summary, we have reported a new case of the rare
entity MMPCT and review the 8 cases published in the
English literature. A careful examination of a proliferation
of round-to-spindle cells with myoid appearance in
a concentric perivascular arrangement along with malig-
nant cytological findings, and positive immunophenotype
for the SMA, will facilitate a prompt diagnosis and the
initiation of appropriate therapy. MMPCTs showed
aggressive biological behavior with metastases occurring
within the first year of evolution. Only 2 cases were free of
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metastatic disease, remarkably one of these cases showed
a focal positivity for cytokeratin (AE1/AE3).4 The follow-
up period for our patient is as yet short-term; the patient is
free of disease after 5 months. It is clear in this study,
however, that metastatic disease can appear later and
a long-term follow-up period is strongly recommended.
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